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MicroRNA-21 dysregulates the expression of MEF2C
in neurons in monkey and human SIV/HIV neurological
disease
SV Yelamanchili1, A Datta Chaudhuri1, L-N Chen1, H Xiong1 and HS Fox*,1

MicroRNAs (miRNAs) have important roles in regulating a plethora of physiological and pathophysiogical processes including
neurodegeneration. In both human immunodeficiency virus (HIV)-associated dementia in humans and its monkey model simian
immunodeficiency virus encephalitis (SIVE), we find miR-21, a miRNA largely known for its link to oncogenesis, to be
significantly upregulated in the brain. In situ hybridization of the diseased brain sections revealed induction of miR-21 in
neurons. miR-21 can be induced in neurons by prolonged N-methyl-D-aspartic acid receptor stimulation, an excitotoxic process
active in HIV and other neurodegenerative diseases. Introduction of miR-21 into human neurons leads to pathological functional
defects. Furthermore, we show that miR-21 specifically targets the mRNA of myocyte enhancer factor 2C (MEF2C), a
transcription factor crucial for neuronal function, and reduces its expression. MEF2C is dramatically downregulated in neurons
of HIV-associated dementia patients, as well as monkeys with SIVE. Together, this study elucidates a novel role for miR-21 in the
brain, not only as a potential signature of neurological disease, but also as a crucial effector of HIV-induced neuronal dysfunction
and neurodegeneration.
Cell Death and Disease (2010) 1, e77; doi:10.1038/cddis.2010.56; published online 23 September 2010
Subject Category: Neuroscience

Many facets of transcriptional and translation regulation
contribute to the proper functioning of the nervous
system. MicroRNAs (miRNAs) are small RNA molecules that
serve as check points in transcription and translation
processes. They largely function by binding to the 30 -UTR
regions of the nascent mRNA molecules resulting in
mRNA destruction or translational inhibition, thus repressing
gene expression.1 miRNAs regulate a plethora of processes
in the central nervous system (CNS) and have been well
documented in neuronal development, neuronal plasticity
and neuronal differentiation. Recognizing the role of miRNA in
neuronal development and control of neuronal functional
elements, it is not surprising that many researchers
have sought to link miRNAs to neurodegenerative
diseases. Consequently, impaired miRNA regulation has
been linked to several neurological diseases including
Parkinson’s disease (PD), Alzheimer’s disease (AD),
Huntington’s disease (HD) and other neurodegenerative
disorders.2,3 Although AD, HD and PD are sporadic and/or
genetic in nature, neurodegeneration also occurs from
infectious etiologies, such as in human immunodeficiency
virus (HIV) infection and transmissible spongiform encephalopathies (prion diseases).
HIV-associated neurocognitive disorders (HAND), varying
in severity from an asymptomatic to a mild neurocognitive
impairment and in its most serious form a debilitating
1

dementia (HIV-associated dementia, HAD), develops in a
subset of individuals infected with HIV-1.4 HAND results from
an indirect neurotoxicity, as HIV infects macrophages and
microglia, but not neurons, in the brain.5,6 We previously
identified dysregulated expression of mRNAs in the brains
of monkeys with simian immunodeficiency virus (SIV)
encephalitis (SIVE) and humans with HIV encephalitis (HIVE),
revealing altered expression of numerous genes including
those expressed in neurons.7,8 Here, we describe the
differential regulation of a crucial miRNA, miRNA-21, in the
brains of individuals with SIVE/HIVE and its increased
expression in neurons both in the brains of diseased subjects
and in vitro upon N-methyl-D-aspartic acid (NMDA) receptor
stimulation. When miR-21 is expressed in human neurons,
electrophysiological abnormalities result, linking its expression to neuronal dysfunction. Given the ability of miRNAs to
modulate cellular mRNAs and proteins and thus cellular
physiology, we identified a critical neuronal transcription
factor, myocyte enhancer factor 2C (MEF2C), as a target of
miR-21. In line with these results, we observe that MEF2C is
downregulated at the protein level in the hippocampus and
frontal cortex of SIVE/HIVE brains. These findings further
underscore the importance of epigenetic changes caused by
miRNA in context of neurological disease and highlights the
regulatory loop, in which miRNAs function and their importance in neurodegenerative research.
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Table 1 Microarray analysis of miRNA expression in control and SIVE/HIVE brains

Log2 median ratios
Control
Probe ID

Infected

Infected versus control

Annotation

Mean

S.D.

Mean

S.D.

DLMR

Fold

t-test

hsa-miR-21
hsa-miR-142-3p
hsa-miR-155
hsa-miR-193a-3p
hsa-miR-142-5p
hsa-miR-516a-5p

1.09
0.84
0.58
0.80
0.84
0.73

0.25
0.41
0.23
0.40
0.28
0.45

0.09
0.35
0.65
0.28
0.51
0.27

0.62
0.82
0.46
0.27
0.40
0.13

1.17
1.18
1.22
1.08
1.35
1.01

2.26
2.27
2.34
2.11
2.55
2.01

0.0126
0.0411
0.0031
0.0101
0.0015
0.0053

Monkey hippocampus
5740
hsa-miR-21
10947
hsa-miR-142-3p
10986
hsa-miR-193a-3p
19015
hsa-miR-142-5p

0.52
1.01
0.79
0.54

0.32
0.50
0.45
0.36

0.80
1.11
0.63
1.16

0.43
0.24
0.38
0.27

1.32
2.12
1.43
1.70

2.50
4.34
2.69
3.24

0.0026
0.0003
0.0029
0.0003

Human caudate
5740
10947
10986
19015

1.414
1.152
0.613
0.858

0.20
0.20
0.47
0.23

0.32
0.25
0.46
0.73

0.68
0.89
0.34
0.92

1.74
1.40
1.08
1.59

3.33
2.63
2.11
3.01

0.0014
0.0123
0.0138
0.0083

Monkey caudate
5740
10947
10964
10986
19015
42550

hsa-miR-21
hsa-miR-142-3p
hsa-miR-193a-3p
hsa-miR-142-5p

RNA from two regions of the monkey and one region of the human brain, as indicated, was analyzed. Shown are the mean and standard deviation (S.D.) of the log2
median ratios for the probes corresponding to individual miRNAs. The difference in the means of the log2 median rations (DLMR) was calculated and the fold change
determined as 2DLMR. Initial candidate miRNAs shown were chosen because of greater than twofold change and a t-test result of Po0.05

Results
miRNAs are significantly upregulated in SIV/HIV CNS
disease. We first examined the expression of miRNAs in
HIVE/SIVE human and monkey samples and control,
using miRNA microarrays on a locked nucleic acid
(LNA) technology-based platform. We compared miRNA
expression in between diseased and control tissue from two
regions of the brain known to be affected in HIV-induced
CNS disease, the striatum (using the caudate nucleus) and
the hippocampus. Both regions were examined in rhesus
monkeys with CNS disease (SIV encephalitis), in humans
with HIV encephalitis and HIV dementia only one region,
the caudate, was available for analysis. In all three sets
of samples, four miRNAs were significantly upregulated,
based on a criterion of twofold change and P-value o0.05
(Table 1). None of the known neuron-enriched miRNAs were
significantly altered. We then validated the expression
change of these four miRNAs by real-time PCR on both
regions of the monkey brains and in the human brain, and
confirmed significant upregulation of three: miR-21, miR-1423p and miR-142-5p (Figure 1). miR-142 expression is largely
confined to the hematopoietic system, whereas miR-21
expression has been found in a number of cell types and
its altered expression linked to pathological changes. miR-21
was therefore chosen for further analysis.
miR-21 is induced in neurons of diseased brains. To
examine the cell type in the brain responsible for the
observed changes in miR-21 expression, in situ hybridization was performed on sections from uninfected and
SIVE monkeys. miR-21 reactivity was minimal in uninfected
monkeys (Figure 2a), and hybridization of a control
scrambled miRNA probe to SIVE brains was negative
Cell Death and Disease

(Figure 2b). In contrast, intense reactivity for miR-21 was
found in brain tissue from animals with SIVE, including cells
morphologically identifiable as neurons (Figure 2c, hippocampus, and 2D, entorhinal cortex). In situ hybridization
was then combined with immunostaining for the neuronspecific protein MAP2, confirming that the upregulation of
miR-21 is in neurons (Figure 3).

miR-21 is upregulated by neuronal stimulation through
NMDA receptors. Neuronal expression has not been
reported for miR-21. In HAND, as well as other neurodegenerative conditions, including AD, PD and HD,
overstimulation of NMDA-type glutamate receptors is a
likely mechanisms of neuronal injury.9 Stimulation of NMDA
receptors leads to neuronal changes through cellular
signaling mechanisms including alterations in gene
expression.10,11 To examine whether miR-21 expression is
part of the response in this pathway, we first performed a
dose-response curve using a range of NMDA exposure for a
prolonged time (1 h) and assessed miR-21 levels 24 h after
the initial exposure in primary neurons from three different
human donors. Indeed, stimulation through NMDA receptors
led to a significant increase in miR-21, with a peak response
at 100 mM (Figure 4a). Under these conditions, there was no
increase in cell death in the cultures (determined by lactate
dehydrogenase release, data not shown). Repeating the
experiment at 100 mM NMDA in four additional independent
donors confirmed the miR-21 upregulation (Figure 4b).
The increased expression was not immediate, as miR-21
expression during the initial exposure to NMDA did not
change (Figure 4c). Furthermore, depolarization of the
neurons with KCl during this same time period did not
induce miR-21 (Figure 4d).
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Figure 1 Altered miRNA expression in SIV/HIV infected brains. (a) Monkey caudate, (b) monkey hippocampus, (c) human caudate. Quantitative real-time PCR confirmed
the upregulation of miR-21, miR-142-3p and miR-142-5p, whereas the change in miR-193-3p did not reach statistical significance. Mean and standard error of the mean
shown, *Po0.05, ***Po0.001

Figure 2 Photomicrographs of monkey brain tissue. In situ hybridization for miR-21 on control uninfected brains is negative (a). In brains with SIVE in situ hybridization with
a scrambled probe (b) is negative, whereas miR-21 (c) is positive in neurons in the hippocampus of SIVE brains. In cortical tissue foci of neurons are positive for miR-21 (d).
The brains of four control and four SIVE animals were examined. The chromagen revealing the positive reaction is blue, and nuclear fast red was used to counterstain cells.
Original magnification 200  (bar ¼ 20 mm) except (d) at 630  (bar ¼ 10 mm)
Cell Death and Disease
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Figure 3 Combined in situ and immunostaining of monkey brain tissue. In situ hybridization for scrambled probe (a) and miR-21 (b) on control uninfected brains is
negative. In brains with SIVE in situ hybridization with a scrambled probe (c) is negative, whereas miR-21 (d) is positive (pink). Anti-MAP2 staining (green) labels the neurons.
Original magnification 200 

miR-21 overexpression affects neuronal physiology.
Although several functions of miR-21 has been reported, the
majority stress its role in various types of cancer and
tumors,12 and its functional significance in neurons has not
been investigated. In order to assess the effects of miR-21
on neuronal function, we transduced primary human neurons
with a lentivirus expressing miR-21 or a control lentivirus
(Figure 5a and b). We then performed electrophysiological
analysis of voltage-gated K þ (Kv) channels, key regulators
of neuronal excitability. Under whole-cell voltage clamp
configuration, application of depolarizing voltage steps
produced larger outward K þ currents in neurons
transfected with a lentivirus expressing miR-21 than the
outward K þ currents recorded in neurons transfected with a
control lentivirus (Figure 5c). When measured at þ 60 mV,
the average instantaneous outward K þ current density
was 311.7±10.9 pA/pF in miR21-transfected neurons
(mean±S.E.M., n ¼ 75). In contrast, the average
instantaneous outward K þ current density recorded in
neurons transfected with viral vector alone was
263.6±11.7 pA/pF (n ¼ 67). The difference was statistically
significant (Po0.001), revealing that miR-21 expression in
neurons produced an enhancement of the outward K þ
current. These data reveal that miR-21 expression is indeed
Cell Death and Disease

detrimental to neurons, and thus, miR-21 induction in
neurons is a potential pathogenic factor in neurodegenerative disorders such as HAD and HAND.
MEF2C is a miR-21 target. With the help of target search
engines, we identified MEF2C as a putative target for miR-21.
MEF2C has been shown to be crucial in multiple aspects of
neuronal development, function and survival,13–15 and in
adult mice MEF2C is critical in learning and memory.16 We
therefore hypothesized that HIV-induced neurocognitive
deficits could be due to repression of the MEF2C mRNA by
miR-21.
To examine whether miR-21 could regulate expression via
the 30 -UTR of the MEF2C mRNA and thereby regulating its
expression, we co-transfected a luciferase reporter vector
containing the MEF2C 30 -UTR along with a vector expressing
either miR-21, a miRNA without a target in the MEF2C 30 -UTR
(miR-181), or a scrambled miRNA sequence in HEK293T
cells. Initial experiments revealed that MEF2C 30 -UTR
expression is repressed by miR-21, but not by a scrambled
control miRNA or an irrelevant miRNA (data not shown). To
assess whether this regulation is indeed because of miR-21
recognizing its predicted binding site in MEF2C rather than
other nonspecific actions, we mutated the miR-21 site in
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Figure 4 Regulation of miR-21 expression in human neurons. The Y axes indicate the fold change, determined as 2–DDCt by normalizing to baseline as 1. (a) miR-21
expression curve for increasing concentrations of NMDA (measured 24 h after a 15 min exposure). Data are from three independent donors/experiments. Repeated measures
one-way ANOVA analysis of the DCt values revealed a significant difference (Po0.001), Tukey’s post hoc test revealed significance between untreated cells and those
treated with NMDA at 25 mM (Po0.05), 100 mM (Po0.001) and 250 mM (Po0.01), and for those treated with 100 mM NMDA compared with those at 25 mM (Po0.05),
250 mM (Po0.05) and 1000 mM (Po0.01). (b) miR-21 expression in four additional donors at the peak (100 mM) NMDA concentration. Paired t-test analysis of the DCt values
revealed a significant difference (Po0.001). (c) miR-21 expression as a result of short-term NMDA stimulations. No significant difference was seen. Data are from three
independent donors/experiments. (d) miR-21 expression as a result of short-term KCl stimulation. No significant difference was seen. Data are from three independent donors/
experiments

MEF2C. Nucleotides 2–8 of the guide strand (known as the
‘seed’ region) are crucial determinants of the specificity of
target recognition by miRNAs. As seen in Figure 6a, there is a
perfect match in the seed sequence between miR-21 and
complementary nucleosides in the 30 -UTR of the MEF2C
mRNA. We then mutated the seed region in MEF2C for miR21 binding (Figure 6a) and performed the luciferase assays as
above. While the wild-type MEF2C shows significant repression by miR-21, the mutant MEF2C does not (Figure 6b). As
an additional control, we also tested a random genomic
sequence within the luciferase vector, which showed no
change upon co-transfection with miR-21.
We next transduced HEK293T cells with miR-21 and a
scrambled control, and examined their effect on the endogenous MEF2C expression. Compared with the controltransduced cells, miR-21 expression decreased MEF2C
expression in cells (Figure 6c). After confirming our results
in HEK293T cells, we transduced human embryonic neurons.
A similar effect was seen in neurons, miR-21 overexpressing
neurons showed a reduction in MEF2C protein levels as
compared with scrambled control (Figure 6d). Our results
clearly demonstrate that MEF2C is repressed by miR-21,
dependent on the seed region, and therefore is a definite
target for miR-21.

MEF2C is repressed in neurons of diseased brains.
MEF2C is expressed in neurons in regions that are
functionally affected in HAND, including the frontal cortex
and hippocampus.17,18 In order to examine whether MEF2C
is altered in neurons in diseased brains we performed
immunohistochemical staining on brain sections control and
diseased monkey (SIVE) and human (with clinical HAD, and
neuropathological HIVE) brains. While neurons from control
brains show robust MEF2C immunoreactivity in neuronal
nuclei (Figures 7a,b, e and f), neurons in the hippocampus
and cortex from diseased monkeys and humans have
a profound decrease in MEF2C protein expression
(Figure7c,d, g and h).

Discussion
In this study, we report for the first time the abnormal induction
of miRNA in neurons in a neurocognitive disorder, HAD/HIVE,
and its animal model, SIVE. Our microarray and follow-up
validation with qPCR in monkeys and humans clearly shows
significant induction of miR-21. Using in situ hybridization on
brain sections we have demonstrated the increase of this
miRNA in neurons.
Cell Death and Disease
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Figure 5 miR-21 alters functional properties of human neurons. (a) Representative image of human fetal brain derived neurons, stained with anti-MAP2 and DAPI.
(b) Representative image of lentiviral transduced neurons, revealing the positive GFP marker in the miR-21 containing FUGW vector. (a and b—original magnification 100  ,
bar ¼ 50 mm). (c) Transduction of human fetal neurons with miR-21 induced an increase of whole-cell outward K þ currents generated by voltage steps shown at the top left. The
representative current traces were recorded from a neuron with the control viral vector (left) and another neuron with the miR-21 viral vector (middle). Note much larger outward K þ
currents were recorded from the miR-21-tranduced neuron than those recorded from the neuron transduced with vector alone. The current-voltage (I–V) relationship (right) showing
the average of current densities recorded in neurons transduced with miR-21 (n ¼ 75) and controls (n ¼ 67), respectively, obtained from three different donors. Mean and standard
error of the mean shown, significance is indicated by *Po0.05, **Po0.01, ***Po0.001. Statistics were performed on data from three independent donors

miR-21 has been shown to be a marker for many types of
cancer including brain gliomas.19 However, neuronal expression has not been previously identified. We find that
stimulation of NMDA receptors leads to increased expression
of miR-21 in neurons. There is precedent for increased NMDA
receptor signaling to be a key component of HIV-induced CNS
disease, as viral proteins such as gp120 and Tat20,21 and
low molecular weight non-proteinaceous products of macrophages,22,23 the key pathogenic cells in the brain, lead to
neuronal damage and death through these receptors. Given
the prime role of NMDA receptors in mechanistic pathways of
neurodegenerative disorders, the induction of miR-21 can
represent a key event in subsequent neuronal injury.
Cell Death and Disease

In order to delineate the functional relevance of miR-21
upregulation in neurons, we examined specific gene targets
for miR-21. While a number of targets for miR-21 have been
uncovered in studies on cancer and other cell types,
we focused our search on targets to neuronal genes. To our
interest, we found MEF2C, a CNS transcription factor as a
target gene for miR-21. While miR-21 is relatively well studied,
this target has not been reported so far for miR-21. One
possible reason for this is many investigators use mouse
models and miRNA target prediction algorithms that rely on
evolutionary conservation. While the miR-21 sequence is well
conserved in mammals and other vertebrates,19 an examination of sequenced genomes reveals that the seed sequence
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Figure 6 MEF2C is a target of miR-21. (a) Alignment and base pairing of miR-21 with the MEF2C 30 -UTR. The seed region (bases 2–8) is indicated in capital letters.
In vitro mutagenesis of the wild-type (wt) MEF2C sequence (upper) to alter the seed sequence and create the mutant (mut) sequence in the seed region is shown in italics
(lower). (b) MiR-21 significantly lowers the activity of the wild-type MEF2C luciferase reporter, but not the mutant MEF2C or a random DNA sequence. This experiment was
repeated in three independent experiments. (c) HEK293T cells or (d) human embryonic neurons were transduced with either control FUGW or miR-21-FUGW lentiviral vector.
Cells were immunostained for MEF2C, as seen in the second panel, the reactivity for MEF2C decreases in miR-21 transduced cells (630  magnification, bar ¼ 10 mm).
Mean and standard error of the mean shown, significance is indicated by **Po0.01

identified within the MEF2C mRNA is present within primates
(human, chimpanzee, rhesus monkey) and many other
mammals (including horse, cow, dog, rabbit, elephant,
platypus), but not in mouse or rat (or opossum). In our study,
as with many others on miRNAs and their targets, this target is
linked to functional defects, however, we note that as each
miRNA has multiple targets, the disease phenotype can be
due to the combined effect of the dysregulated miRNA on
numerous genes.
Our results clearly demonstrate that MEF2C is repressed
by miR-21, dependent on the seed region, and therefore,
is a definite target for miR-21. MEF2C has been of much
interest to neuroscientists. It has been shown to be crucial for
neuronal survival and its complete deficiency experimentally
leads to an autism-like phenotype in mice.13,14 Other studies
have found that in adult mice MEF2C is critical in learning and
memory.16 While no deficits have been reported in mice
carrying only one functional copy of MEF2C, in humans
a number of investigators have recently reported that
haploinsufficiency of MEF2C leads to severe mental retardation.24 Thus, similar to the targeting of MEF2C by miR-21,
the functions of MEF2C are not fully captured in rodent
models.

In order to look for functionality of miR-21 expression in
neurons, we performed electrophysiological studies on
neurons transfected with lentiviruses expressing miR-21.
The results clearly showed that expression of miR-21 resulted
in a significant enhancement of outward K þ current. Such an
increase is an early step in neuronal apoptosis, before
commitment to cell death,25 although we did not observe
neuronal death due to miR-21 expression at the time point
when electrophysiological studies were performed. While the
biological significance of miR-21-induced enhancement of
neuronal outward K þ current remains to be determined, we
postulate it might reflect a part of pathogenesis of neurodegenerative disorders such as HAD. Genetic targeting studies
reveal that Kv channels have a great importance in the
memory processes.26,27 Intriguingly, it has been also shown
that MEF2 proteins target Kv1.1.28 We do not know as of now
whether MEF2C in particular would directly target potassium
channel genes, but it is a fascinating aspect to consider.
Interestingly, loss of MEF2C in mice leads to increased
neuronal excitatory input.16 One possibility is that an
autostimulatory cycle is created, increased excitatory input
through NMDA receptors leads to increased miR-21 and
decreased MEF2C, resulting in further increased excitatory
Cell Death and Disease
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Figure 7 Photomicrographs of monkey and human brain tissue. Immunohistochemical staining for MEF2C reveals positive staining in hippocampal (a) and cortical (b)
neurons of control uninfected monkeys. In monkeys with SIVE much less reactivity is seen in hippocampal (c) and cortical neurons (d). Tissue from four monkeys in each group
was examined. The same result is seen in the cortex of humans, with stronger reactivity is seen in neurons in the frontal cortex of brains from individuals without HIV
neurological symptoms (e and f, representing two of the four cases examined) when compared with those with HIV-associated dementia (g and h, representing two of
the three cases examined). The chromagen revealing the positive reaction is brown, and methyl green (light green) used for counterstaining. Original magnification
200  (bar ¼ 20 mm) except inserts at 630  (bar ¼ 10 mm)

Cell Death and Disease
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Figure 8 Model of autostimulatory neuropathogenic cycle. In CNS HIV infection, NMDA receptors (NMDA-R) can be activated through their normal ligand glutamate, as
well as HIV proteins and/or excitatory molecules from macrophages. This increased excitatory input results in induction of miR-21 that decreases MEF2C, resulting in further
increased excitatory input. This neuronal damage, along with alterations in the other neuronal functions involving MEF2C, results in cognitive dysfunction

input, which maintains or further increases miR-21 and
decreases MEF2C (Figure 8). Such a cycle would result in
neuronal dysfunction and possibly excitotoxic death.
miRNA expression in frontal cortical gray matter miRNAs
was examined in another study looking at the effect of
depression in HIV infected individuals, but miR-21 was not
identified as having this association.29 In addition, similar to
our studies with NMDA treatment of human neurons, the HIV
protein Tat was used to treat rodent neurons, revealing the
upregulation of miR-128a but not miR-21.30 However, there
are significant interspecies differences between rodent and
human neurons in response to Tat,31 and such studies would
need to be repeated with human neurons. Thus, it is possible
that in addition to NMDA, viral proteins as well as other
molecules implicated in the neuropathogenesis of HIV could
result in alterations of miR-21 in human neurons (Figure 8).
Interestingly, another recently reported study examined
miRNAs in subcortical white matter in HIVE, and found a
number of up- and down-regulated molecules.32 In that study,
downregulation of miRNAs was linked to increased caspase-6
in astrocytes and astrocyte injury. miR-21 was not identified,
likely because of the examination of white matter versus the
neuron-rich regions studied here. Infiltration and activation of
macrophages in the brain is a well-characterized neuropathological component of SIVE/HIVE. While miRNAs have also
been studied in macrophages in relationship to HIV infection

and interferon production,33,34 changes in miR-21 or others
miRNAs in macrophages in CNS disease have not yet been
reported.
Our data provides compelling evidence that MEF2C is an
important target for miR-21 in neurons. miR-21 induction,
through repression of MEF2C and potentially other genes,
could lead to deficits in neurocognitive functions as seen in
HIV infection and possibly other disorders. These studies also
reveal additional reasons why rodent systems may not be
optimal for the study of certain neurodegenerative conditions.35 Our study in humans and nonhuman primates thereby
provides a unique mechanism of disease: neuronal induction
of miRNAs in a setting of CNS infection, revealing a novel
mechanism of dysregulation of CNS function and providing
new avenues in brain research.
Materials and Methods
Ethics statement. The monkey samples were from rhesus macaques used in
our previous studies on SIV pathogenesis36,37 that were performed under IACUC
approval from The Scripps Research Institute. Human RNA samples were obtained
from the National NeuroAIDS Tissue Consortium (NNTC) (http://www.nntc.org),
operating under IRB approval from the participating institutions (University of
California San Diego, University of California Los Angeles, University of Texas
Medical Branch at Galveston, and Mt. Sinai Medical Center in New York). Fetal
brain tissue for primary neuronal culture was obtained in full compliance with the
ethical guidelines of the NIH and under IRB approval from the University of
Washington and the University of Nebraska Medical Center.
Cell Death and Disease
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miRNA microarray studies. Total cellular RNA was isolated from frozen
(801C) brain specimens by using TRIzol (Invitrogen, Carlsbad, CA, USA) for
the monkey samples, and RNAzol (Biotecx Laboratories, Houston, TX, USA) for the
human samples, followed by column purification (miRNeasy, Qiagen, Valencia, CA,
USA) as per manufacture’s instructions. For the monkeys, four samples were from
uninfected animals and four from SIV-infected animals that developed simian AIDS
with SIV encephalitis. For the human samples, six samples were from individuals
who were HIV negative with no history of dementia or neurocognitive disability and
showed no significant neuropathology. Five samples were from HIV positive
individuals that were neurocognitively impaired (NNTC clinical rating 46)38 and a
neuropathological diagnosis of HIV encephalitis. Clinical information is provided
in the supplemental material. For microarray analysis, only three of the HAD
specimens were sufficient for use, but all five were used for the qRT-PCR studies.
miRNA microarray analysis was performed by using the miRCURY LNA
microarray (version 11.0) microRNA at Exiqon S/A (Vedbaek, Denmark). The
microarray data have been deposited in NCBI’s gene expression omnibus and are
accessible through GEO (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?).

cell suspension was cultured on poly-D-lysine-coated plates in neurobasal media
containing 0.5 mM l-glutamine, 50 mg/ml penicillin and streptomycin and
supplemented with B27 (Invitrogen). Matured neurons were stained with a
neuronal-specific MAP2 antibody (Calbiochem, San Diego, CA, USA) to confirm the
purity.
For NMDA and KCL treatments, neurons were grown to 15 days in vitro (DIV)
and cultures were then treated with the indicated concentrations of NMDA and
10 mM glycine. After 1 h treatment, cultures were replaced with normal neuronal
medium. After 24 h, the neurons were collected in TRIzol and RNA was extracted for
analysis. For KCL stimulation, treatment was carried out for 15 min at the indicated
concentrations before the extraction of RNA.
For lentivirus transduction, neurons were transduced with miR-21 or control
lentivirus at a biological titer of 1  1010 transduction units/ml at 7 DIV. Neurons
were cultured for another 4 days after transduction, used for MEF2C
immunofluorescence or electrophysiology, which was performed on GFP positive
cells.

miRNA quantitative real-time PCR (qRT-PCR). For the brain RNA
samples, qRT-PCR was performed on the same samples used for microarray
analysis above at Exiqon. Endogenous controls were chosen based on their relative
stability on the microarrays, and the three best endogenous controls (let-7e, let-7C,
and miR-423-3p) were used for normalizing the quantified signal of the miRNAs. For
the primary human neuronal culture RNA samples, Taqman qRT-PCR assays for
hsa-miR-21 and U6 snRNA for endogenous control were purchased and performed
as per manufacturer’s instructions from (ABI, Carlsbad, CA, USA).
The relative expressions were calculated based on the efficiency corrected Ct
method; the PCR efficiency was estimated from a serial dilution of cDNA generated
from pooled RNA of the samples. Data (in log2 format) were exported into Excel
(Microsoft, Redmond, WA, USA) and analyzed for differential expression by using
the two-tailed Student’s t-test (for two-group comparisons) or into Prism (GraphPad
Software, San Diego, CA, USA) for one-way ANOVA followed by post hoc testing
(for multiple group comparisons).

miR-21 expressing lentivirus. We generated a miR-21 lentiviral vector by
subcloning the precursor miR-21 fragment into the Pac1/Nhe1 cloning sites of the
FUGW, a self inactivating, replication incompetent lentiviral vector that carries the
human ubiquitin-C promoter driving a GFP reporter gene. Human embryonic kidney
293 T cells were transfected by using Fugene 6 (Roche Applied Science,
Indianapolis, IN, USA) with the expression vector and two helper plasmids, D8.9
and vesicular stomatitis virus G protein. Virions were isolated by ultracentrifugation
of filtered supernatant. For the control virus, the vector without the miR-21 insert was
used.

miRNA in situ hybridization. Following necropsy, monkey caudate and
hippocampus were formalin fixed, and embedded in paraffin, and 5 mm sections cut
onto glass slides. The in situ hybridization was performed at Phylogeny Inc.
(Columbus, OH, USA) as described previously.39 Monkey spleen was used as a
positive control. At least two hybridizations were done for each probe on each brain
section.
Combined in situ hybridization and immunofluorescence. We
adapted our protocol for radiolabelled in situ hybridization and colorimetric
immunohistochemisty7 to fluorescence as follows. Following deparaffinization
and antigen retrieval with citrate, sections were pre-hybridized in hybridization buffer
(50% formamide, 10 mM Tris-HCl, pH 8.0, 200 mg/ml yeast tRNA, 1  Denhardt’s
solution, 600 mM NaCl, 0.25% SDS, 1 mM EDTA, 10% dextran sulfate) for 1 h at
371C in a humidified chamber. LNA modified miR-21 and scrambled miR probes,
labeled at both the 50 and 30 ends with digoxigenin (Exiqon), were diluted to final
concentration of 2 pM in hybridization buffer, heated to 651C for 5 min, and
separately hybridized to the sections at 371C overnight. The slides were then
washed twice in hybridization buffer (without probe) at 371C, followed by washing
three times in 2  SSC and twice in 0.2  SSC at 421C. They were then blocked
with 1% BSA, 3% normal goat serum in 1  PBS for 1 h at room temperature and
incubated with anti-digoxigenin conjugated with horseradish peroxidase (1:100,
Roche Diagnostics GmbH, Mannheim, Germany) and anti-MAP2 (1:1500,
Sternberger Monoclonals Inc., Baltimore, MD, USA) antibodies overnight at 41C.
The slides were washed twice with PBS and incubated with Alexa Fluor 568 goat
anti-mouse IgG (1:400, Invitrogen) antibody for 1 h at room temperature. This was
followed by two PBS washes and signal amplification (for the in situ, now labeled
with horseradish peroxidae) using TSA Cy5 kit (PerkinElmer, Waltham, MA, USA)
according to the manufacturer’s protocol. The slides were mounted in Prolong gold
anti-fade reagent with DAPI (Invitrogen).
Isolation, cultivation and treatments of human neurons. Fetal
brain tissue (first/second trimester) was obtained from the Birth Defects Laboratory,
University of Washington, Seattle, WA, USA. Neuronal cultures were prepared by
incubating dissociated tissue with 0.25% trypsin for 30 min, neutralized with 10%
fetal bovine serum, and further dissociating by triturating. The resulting single
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Electrophysiology. Whole-cell voltage-clamp recordings were performed on
transduced (GFP-positive) primary human neuronal cultures (from three donors) in
35 mm tissue culture dishes on the stage of an inverted Nikon microscope (TE 300)
using an Axonpatch 200B amplifier (Molecular Devices, Sunnyvale, CA, USA).
Patch electrodes, made from borosilicate glass micropipettes (WPI Inc., Sarasota,
FL, USA) with a P-97 micropipette puller (Sutter Instruments, Novato, CA, USA),
had tip resistance of 5.0–8.0 MO. The electrodes were advanced toward cells by a
Burleigh micromanipulator (PC-5000, EXFO, Mississauga, ON, Canada). After
establishment of the whole-cell patch configuration, the cells were allowed to
stabilize for 3–5 min before tests. The recorded cells were held at 60 mV during
voltage clamping. Whole-cell outward K þ currents were induced by applying
depolarizing voltage steps (300 ms in duration) from the holding potential of
60 mV to 40 mV in the first step, and then stepped to þ 60 mV in increments of
10 mV. Junction potentials were corrected, and the cell capacitance was
uncompensated. Current signals were filtered at 1 kHz and digitized at 5 kHz
using Digidata 1440A digitizer (Molecular Devices). The current and voltage traces
were displayed and recorded in a Dell computer using pCLAMP 10.2 data
acquisition/analysis system (Molecular Devices).
The pipette and extracellular solutions for voltage-clamp experiments were as
described by Sodickson et al.40 In order to block voltage-gated sodium channels,
1.0 mM tetrodotoxin (Tocris Bioscience, Ellisville, MO, USA) was added to the
extracellular solution. All experiments were done at room temperature (22–231C).
Data was analyzed using Clampfit 10.2 software (Molecular Devices). For I–V
curves, the current densities of the instantaneous outward K þ currents, generated
by voltage steps, were measured and analyzed in each group. Student’s t-test (twotailed) was employed for statistical analyses.
30 -UTR analysis for miRNA regulation. The MEF2C 30 -UTR luciferase
reporter vector was purchased from Switchgear Genomics (Menlo Park, CA, USA),
and the precursor miRNA containing vectors from Cellbiolabs (San Diego, CA,
USA). Site-directed mutagenesis was performed using the QuickChange Lightning
kit (Stratagene, La Jolla, CA, USA). To test suppression by miRNA, the miRNA of
interest was co-transfected into HEK293T cells with the indicated 30 -UTR luciferase
reporter and with Renilla luciferase (pRL-TK Vector, Promega, Madison, WI, USA)
as a transfection efficiency control. The luciferase signal was measured with DuoGlo luciferase assay kit (Promega). The normalized data (the signal from the 30 -UTR
firefly luciferase to the control Renilla luciferase) were imported into Prism
(GraphPad Software) and analyzed by one-way ANOVA. When the ANOVA P-value
was o0.05 the Newman–Kuels multiple comparison test was used to assess group
differences.
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MEF2C immunostaining. A rabbit monospecific anti-MEF2C antibody
(Human Protein Atlas antibody ID# HPA005533 from the Human Proteome
Resource program, distributed by Sigma, St. Louis, MO, USA) was used for
all studies. Immunofluorescence was performed on cells transduced with GFPexpressing lentiviral control and miR-21 constructs. An Alexaflour 488 goat-anti
rabbit secondary antibody (Invitrogen) was used for detection followed by mounting
with Prolong gold antifade reagent containing DAPI (Invitrogen).
Immunohistochemistry was performed on 5–6 mm formalin-fixed, paraffinembedded tissue blocks from the monkey hippocampus and human frontal cortex.
Antigen retrieval was performed by heating in citrate buffer. For detection,
SuperPicture broad spectrum secondary antibody-horseradish peroxidase polymer
reagent (Invitrogen) was used followed by chromogenic development with 3,30 diaminobenzidine and a methyl-green counterstain.
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